TSHA
Taysha GeneยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
TSHA Profile
Taysha Gene Therapies, Inc.
A clinical-stage gene therapy company focused on developing treatments for rare genetic diseases
Biological Technology
09/20/2019
09/24/2020
NASDAQ Stock Exchange
73
12-31
Common stock
3000 Pegasus Park Dr. Ste 1430, Dallas, Texas 75247
--
Taysha Gene Therapies, Inc. was originally incorporated under Texas law on September 20, 2019. The Company was converted to a Delaware corporation on February 13, 2020. The Company is a patient-centric gene therapy company dedicated to the development and development of commercialized AAV-based gene therapies for the treatment of rare and large patient populations of central nervous system monogenic diseases.
